MolVerse
MolVerse offers a practical platform for preclinical drug development by reducing reliance on animal models and enabling study of human and pathogenic samples. It achieves this through a deeptech toolkit that combines quantum chemistry, high-throughput cryogenic electron microscopy, and GPU-accelerated high-performance computing, enhanced by machine learning and image processing to produce near-atomic 3D maps. The company targets biopharma and academic research institutes, delivering a B2B solution for structure-function analyses, biomolecular mapping, and reproducible discovery pipelines. Its approach emphasizes efficiency, cost savings, and data reproducibility across life sciences and drug development beyond traditional models. MolVerse positions itself in the life sciences technology market as a scalable platform for preclinical discovery and molecular research on a global scale.
MolVerse
MolVerse offers a practical platform for preclinical drug development by reducing reliance on animal models and enabling study of human and pathogenic samples. It achieves this through a deeptech toolkit that combines quantum chemistry, high-throughput cryogenic electron microscopy, and GPU-accelerated high-performance computing, enhanced by machine learning and image processing to produce near-atomic 3D maps. The company targets biopharma and academic research institutes, delivering a B2B solution for structure-function analyses, biomolecular mapping, and reproducible discovery pipelines. Its approach emphasizes efficiency, cost savings, and data reproducibility across life sciences and drug development beyond traditional models. MolVerse positions itself in the life sciences technology market as a scalable platform for preclinical discovery and molecular research on a global scale.